Srs Capital Advisors, Inc. Tenaya Therapeutics, Inc. Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 105 shares of TNYA stock, worth $196. This represents 0.0% of its overall portfolio holdings.
Number of Shares
105Holding current value
$196% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
97Shares Held
55.6MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$17.6 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$14.3 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$12.6 Million1.81% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$7.62 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$6.57 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $77.4M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...